Seminole county adult treatment court - project name: seminole county adult treatment court - expanding SUD treatment capacity applicant: seminole county, florida – nofo: TI-26-015 the seminole county…

The Substance Abuse and Mental Health Services Administration awarded Seminole County $399,622 under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) on September 30, 2026, to expand substance use disorder treatment capacity through the Seminole County Adult Treatment Court.

The award funds five years of operations for the court, which since 2001 has admitted 1,082 participants and graduated 617 with a 6.6 percent cumulative recidivism rate. The funding embeds a licensed treatment court clinical coordinator and a program intake specialist within the existing multidisciplinary team and strengthens recovery support services for 50 unduplicated participants annually, totaling 250 over the five-year period. The court serves adults age 18 and older charged with non-violent felony offenses with a primary substance use disorder diagnosis in Seminole County's 18th Judicial Circuit northeast of Orlando.

The project implements all ten required activities: comprehensive screening and assessment, naloxone distribution and overdose training, evidence-based treatment including cognitive behavioral therapy, motivational enhancement therapy, Seeking Safety, and eye movement desensitization and reprocessing, medication for opioid and alcohol use disorders, trauma-informed care, peer recovery support, evidence-based drug testing, family engagement, infectious disease screening, and workforce training. Primary substances in the active caseload are alcohol (41 percent) and opioids (28 percent).

Year-one targets include reducing referral-to-treatment time by 25 percent from a baseline of 78.1 days and achieving 70 percent 90-day retention. By year three, the court aims to reach a 60 percent graduation rate and ensure 100 percent of opioid-involved participants receive naloxone at enrollment.

Period of performance runs through September 29, 2031, with place of performance in Sanford, Florida.

Seminole county adult treatment court - project name: seminole county adult treatment court - expanding SUD treatment capacity applicant: seminole county, florida – nofo: TI-26-015 the seminole county adult treatment court (ATC) requests five years of samhsa funding to expand substance use disorder (SUD) treatment capacity by embedding a licensed treatment court clinical coordinator and a program intake specialist within its existing multidisciplinary team and strengthening recovery support services for 50 unduplicated participants annually (250 over five years). Operating since 2001 within the 18TH judicial circuit northeast of orlando, the ATC has admitted 1,082 participants, graduated 617, and maintains a 6.6 percent cumulative recidivism rate. Geographic area and population. Seminole county spans 344 square miles with approximately 455,479 residents. The ATC serves adults age 18 and older charged with non-violent felony offenses with a primary SUD diagnosis, ranging primarily from ages 26 to 45 (38 percent female, 62 percent male). Alcohol (41 percent) and opioids (28 percent) account for nearly 70 percent of the active caseload. CO-occurring trauma is prevalent, and participants are high-risk felony-level offenders who would otherwise cycle through incarceration without intervention. Strategies and interventions. The project implements all ten nofo-required activities: comprehensive screening and assessment; naloxone distribution and overdose training; evidence-based treatment (CBT, met, seeking safety, emdr); moud/maud; trauma-informed care; peer recovery support; evidence-based drug testing; family engagement; infectious disease screening; and ongoing workforce training. Goals and objectives. Reduce referral-to-treatment time by 25 percent from the FY2025 baseline of 78.1 days (year 1); achieve 70 percent 90-day retention (year 1); reach a 60 percent graduation rate (year 3); ensure 100 percent of opioid-involved participants receive naloxone at enrollment (year 1); and secure non-federal funding for the clinical coordinator position beyond the grant period (year 5).